Abstract
For more than two decades, retroviral biology has been the most intensely studied field in virology. The retroviral genome is encoded by a 7–11 kb positivesense single-stranded RNA molecule, two of which homodimerize and package in lipid-enveloped viral particles. Following attachment and receptor-mediated entry into host cells, viral reverse transcriptase and integrase enzymes mediate reverse transcription and integration of the virus genome into the host-cell chromatin. The ability of a replication competent retrovirus to incorporate a herpes simplex virus thymidine kinase (tk) gene into the genome of a mouse cell and to convert NIH-3T3 TK- cells into TK+ transformants was first described in 1981 (1,2). These studies established the basis of using retroviruses as vehicles for efficient therapeutic gene delivery into mammalian cells. Twenty years of extensive research of retrovirus-vector biology resulted in major improvements in vector design and retrovirus-vector production. High-titer concentrated retrovirus vectors (>109 infectious units [IU]/mL) can be generated by several retrovirus-vector stable producer lines. The ability to pseudotype retrovirus vectors with a variety of envelope proteins, including the vesicular stomatitis virus G glycoprotein (VSV-G), significantly broadens the tropism of replication-defective retrovirus vectors. In addition, combinations of synthetic and tissue-specific promoters, which were incorporated into retrovirus vectors, allowed long-term and regulated gene expression in vector transduced cells.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Shimotohno, K. and Temin, H. M. (1981) Formation of infectious progeny virus after insertion of herpes simplex thymidine kinase gene into DNA of an avian retro-virus. Cell 26, 67–77.
Wei, C. M., Gibson, M., Spear, P. G., and Scolnick, E. M. (1981) Construction and isolation of a transmissible retrovirus containing the src gene of Harvey murine sarcoma virus and the thymidine kinase gene of herpes simplex virus type 1. J. Virol. 39, 935–944.
Cavazzana-Calvo, M., Hacein-Bey, S., de Saint Basile, G., et al. (2000) Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288, 669–672.
Lewis, P., Hensel, M., Emerman, M. (1992) Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J. 11, 3053–3058.
Gallay, P., Swingler, S., Song, J., Bushman, F., and Trono, D. (1995) HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 83, 569–576.
Gallay, P, Stitt, V., Mundy, C., Oettinger, M., and Trono, D. (1996) Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import. J. Virol. 70, 1027–1032.
Gallay, P., Hope, T., Chin, D., and Trono, D. (1997) HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc. Natl. Acad. Sci. USA 94, 9825–9830.
Kim, V. N., Mitrophanous, K., Kingsman, S. M., and Kingsman, A. J. (1998) Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1. J. Virol. 72, 811–816.
Naldini, L., Blomer, U., Gallay, P., et al. (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector [see comments]. Science 272, 263–267.
Kafri, T., Blomer, U., Peterson, D. A., Gage, F. H., and Verma, I. M. (1997) Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat. Genet. 17, 314–317.
Akkina, R. K., Walton, R. M., Chen, M. L., Li, Q. X., Planelles, V., and Chen, I. S. (1996) High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J. Virol. 70, 2581–2585.
Aiken C. (1997) Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. J. Virol. 71, 5871–5877.
DePolo, N. J, Reed, J. D., Sheridan, P. L., et al. (2000) VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum. Mol. Ther. 2, 218–222.
Higashikawa, F. and Chang, L. (2001) Kinetic analyses of stability of simple and complex retroviral vectors. Virology 280, 124–131.
Christodoulopoulos, I. and Cannon, P. M. (2001) Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors. J. Virol. 75, 4129–4138.
Stitz, J., Buchholz, C. J., Engelstadter, M., et al. (2000) Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1. Virology 273, 16–20.
Olsen, J. C., Kelly, M., Patel, M., and Johnson, L. G (1999) Gene delivery to murine trachea by an equine lentiviral vector. Pediatr. Pulmonol. Suppl. 19: 222 (Abstr.).
Kobinger, G P., Weiner, D. J., Yu, Q. C, and Wilson, J. M. (2001) Filovirus-pseudo-typed lentiviral vector can efficiently and stably transduce airway epithelia in vivo. Nat. Biotechnol. 19, 225–230.
Wang, B., Ge, Y. C., Palasanthiran, P., et al. (1996) Gene defects clustered at the C-terminus of the vpr gene of HIV-1 in long-term nonprogressing mother and child pair: in vivo evolution of vpr quasispecies in blood and plasma. Virology 223, 224–232.
Kirchhoff, F., Greenough, T. C., Brettler, D. B., Sullivan, J. L., and Desrosiers, R.C. (1995) Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332, 228–232.
Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., and Trono, D. (1997) Multiply attenuated lentiviral vector acheives efficient gene delivery in vivo. Nat. Biotechnol. 15, 871–875.
Dull, T., Zufferey, R., Kelly, M., et al. (1998) A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72, 8463–8471.
Chinnasamy, D., Chinnasamy, N., Enriquez, M. J., Otsu, M., Morgan, R. A., and Candotti, F. (2000) Lentiviral-mediated gene transfer into human lymphocytes: role of HIV-1 accessory proteins. Blood 96, 1309–1316.
Costello, E., Munoz, M., Buetti, E., Meylan, P. R., Diggelmann, H., and Thali, M. (2000) Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors. Gene Ther. 7, 596–604.
Shen, H., Cheng, T., Preffer, F. I., et al. (1999) Intrinsic human immunodeficiency virus type 1 resistance of hematopoietic stem cells despite coreceptor expression. J. Virol. 73, 728–737.
Kotsopoulou, E., Kim, V. N., Kingsman, A. J., Kingsman, S. M., and Mitrophanous, K. A. (2000) A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene. J. Virol. 74, 4839–4852.
Wu, X., Wakefield, J. K., Liu, H., et al. (2000) Development of a novel trans-lentiviral vector that affords predictable safety. Mol. Ther. 2, 47–55.
Miyoshi, H., Blomer, U., Takahashi, M., Gage, F. H., and Verma, I. M. (1998) Development of a self-inactivating lentivirus vector. J. Virol. 72, 8150–8157.
Iwakuma, T., Cui, Y., and Chang, L. J. (1999) Self-inactivating lentiviral vectors with U3 and U5 modifications. Virology 261, 120–132.
Zufferey, R., Dull, T., Mandel, R. J., et al. (1998) Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72, 9873–9880.
Zufferey, R., Donello, J. E., Trono, D., and Hope, T. J. (1999) Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J. Virol. 73, 2886–2892.
Zennou, V., Petit, C., Guetard, D., Nerhbass, U., Montagnier, L., and Charneau, P. (2000) HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101, 173–185.
Charneau, P., Alizon, M., and Clavel, F. (1992) A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication. J. Virol. 66, 2814–2820.
Charneau, P., Mirambeau, G., Roux, P., Paulous, S., Buc, H., and Clavel, F. (1994) HIV-1 reverse transcription. A termination step at the center of the genome. J. Mol. Biol. 241, 651–662.
Zennou, V., Serguera, C, Sarkis, C, et al. (2001) The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain. Nat. Biotechnol. 19, 446–450.
Sirven, A., Pflumio, F., Zennou, V., et al. (2000) The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells. Blood 96, 4103–4110.
Sirven, A., Ravet, E., Charneau, P., et al. (2001) Enhanced transgene expression in cord blood cd34(+)-derived hematopoietic cells, including developing t cells and nod/scid mouse repopulating cells, following transduction with modified trip lentiviral vectors. Mol. Ther. 3, 438–448.
Pfeifer, A., Kessler, T, Yang, M., et al. (2001) Transduction of liver cells by lentiviral vectors: analysis in living animals by fluorescence imaging. Mol. Ther. 3, 319–322.
Follenzi, A., Ailles, L. E., Bakovic, S, Geuna, M., and Naldini, L. (2000) Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat. Genet. 25, 217–222.
Kafri, T, van Praag, H., Gage, F. H., and Verma, I. M. (2000) Lentiviral vectors: regulated gene expression. Mol. Ther. 1, 516–521.
Reiser, J., Lai, Z., Zhang, X. Y., and Brady, R. O. (2000) Development of multigene and regulated lentivirus vectors. J. Virol. 74, 10589–10599.
Gossen, M. and Bujard, H. (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89, 5547–5551.
Haack, K. and Kafri, T (2001) Development of second generation inducible lentiviral vectors. Mol. Ther. 3, S2.
Scherr, M., Battmer, K., Blomer, U., Ganser, A., and Grez, M. (2001) Quantitative determination of lentiviral vector particle numbers by real-time PCR. Biotechniques 31, 520, 522, 524, passim.
Kafri, T, van Praag, H., Ouyang, L., Gage, F. H., and Verma, I. M. (1999) A packaging cell line for lentivirus vectors. J. Virol. 73, 576–584.
Pacchia, A. L., Adelson, M. E., Kaul, M., Ron, Y., and Dougherty, J. P. (2001) An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins. Virology 282, 77–86.
Klages, N., Zufferey, R., and Trono, D. (2000) A stable system for the high-titer production of multiply attenuated lentiviral vectors. Mol. Ther. 2, 170–176.
Xu, K., Ma, H., McCown, T J., Verma, I. M., and Kafri, T. (2001) Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors. Mol. Ther. 3, 97–104.
Farson, D., Witt, R., McGuinness, R., et al. (2001) A new-generation stable inducible packaging cell line for lentiviral vectors. Hum. Gene Ther. 12, 981–997.
Hansen, M. S., Smith, G J., 3rd, Kafri, T., Molteni, V., Siegel, J. S., and Bushman, F. D. (1999) Integration complexes derived from HIV vectors for rapid assays in vitro. Nat. Biotechnol. 17, 578–582.
Naldini, L., Blomer, U., Gage, F. H., Trono, D., and Verma, I. M. (1996) Efficient gene transfer, integration, and sustained long-term expression in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93, 11382–11388.
Blomer, U., Naldini, L., Kafri, T., Trono, D., Verma, I. M., and Gage, F. H. (1997) Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. 71, 6641–6649.
Bensadoun, J. C., Deglon, N., Tseng, J. L., Ridet, J. L., Zurn, A. D., and Aebischer, P. (2000) Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson’s disease using GDNF. Exp. Neurol. 164, 15–24.
Kordower, J. H., Bloch, J., Ma, S. Y., et al. (1999) Lentiviral gene transfer to the nonhuman primate brain. Exp. Neurol. 160, 1–16.
Deglon, N., Tseng, J. L., Bensadoun, J. C, et al. (2000) Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson’s disease. Hum. Gene Ther. 11, 179–190.
Lai, Z., Han, I., Zirzow, G., Brady, R. O., and Reiser, J. (2000) Intercellular delivery of a herpes simplex virus VP22 fusion protein from cells infected with lentiviral vectors. Proc. Natl. Acad. Sci. USA 97, 11297–11302.
Bosch, A., Perret, E., Desmaris, N., Trono, D., and Heard, J. M. (2000) Reversal of pathology in the entire brain of mucopolysaccharidosis type VII mice after lentivirus-mediated gene transfer. Hum. Gene Ther. 11, 1139–1150.
Consiglio, A., Quattrini, A., Martino, S., et al. (2001) In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice. Nat. Med. 7, 310–316.
Blomer, U., Kafri, T., Randolph-Moore, L., Verma, I. M, and Gage, F. H. (1998) Bcl-xL protects adult septal cholinergic neurons from axotomized cell death. Proc. Natl. Acad. Sci. USA 95, 2603–2608.
Bjorklund, A., Kirik, D., Rosenblad, C., Georgievska, B., Lundberg, C., and Mandel, R. J. (2000) Towards a neuroprotective gene therapy for Parkinson’s disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model. Brain Res. 886, 82–98.
Kordower, J. H., Emborg, M. E., Bloch, J., et al. (2000) Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson’s disease. Science 290, 767–773.
Benhamida, S., Pflumio, F., Fichelson, S., et al. (2001) HIV-flap mediated gene therapy for adrenoleukodystrophy: efficient correction of hematopoietic stem cells using short clinically applicable protocole. Mol. Ther. 3, S327.
Kootstra, N., Matsumura, R., and Verma, I. (2001) Gene therapy for hemophilia A using lentiviral vectors. Mol. Ther. 3, S221.
Miyoshi, H., Smith, K. A., Mosier, D. E., Verma, I. M., and Torbett, B. E. (1999) Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 283, 682–686.
Guenechea, G., Gan, O. I., Inamitsu, T., et al. (2000) Transduction of human CD34+ CD38-bone marrow and cord blood-derived SCID-repopulating cells with third-generation lentiviral vectors. Mol. Ther. 1, 566–573.
An, D. S., Wersto, R. P., Agricola, B. A., et al. (2000) Marking and gene expression by a lentivirus vector in transplanted human and nonhuman primate CD34(+) cells. J. Virol. 74, 1286–1295.
Douglas, J., Kelly, P., Evans, J. T., and Garcia, J. V. (1999) Efficient transduction of human lymphocytes and CD34+ cells via human immunodeficiency virus-based gene transfer vectors. Hum. Gene Ther. 10, 935–945.
Douglas, J. L., Lin, W. Y., Panis, M. L., and Veres, G. (2001) Efficient human immunodeficiency virus-based vector transduction of unstimulated human mobilized peripheral blood CD34+ cells in the SCID-hu Thy/Liv model of human T cell lymphopoiesis. Hum. Gene Ther. 12, 401–413.
Chen, W., Wu, X., Levasseur, D. N., et al. (2000) Lentiviral vector transduction of hematopoietic stem cells that mediate long-term reconstitution of lethally irradiated mice. Stem Cells 18, 352–359.
Donahue, R. E., Sorrentino, B. P., Hawley, R. G., An, D.S., Chen, I. S., and Wersto, R. P. (2001) Fibronectin fragment CH-296 inhibits apoptosis and enhances ex vivo gene transfer by murine retrovirus and human lentivirus vectors independent of viral tropism in nonhuman primate CD34(+) cells. Mol. Ther. 3, 359–367.
Haas, D. L., Case, S. S., Crooks, G. M., and Kohn, D. B. (2000) Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors. Mol. Ther. 2, 71–80.
Mikkola, H., Woods, N. B., Sjogren, M., et al. (2000) Lentivirus gene transfer in murine hematopoietic progenitor cells is compromised by a delay in proviral integration and results in transduction mosaicism and heterogeneous gene expression in progeny cells. J. Virol. 74, 11911–11918.
Salmon, P., Kindler, V., Ducrey, O., Chapuis, B., Zubler, R. H., and Trono, D. (2000) High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors. Blood 96, 3392–3398.
Yamada, K., Olsen, J. C., Patel, M., Rao, K. W., and Walsh, C. E. (2001) Functional correction of fanconi anemia group c hematopoietic cells by the use of a novel lentiviral vector. Mol. Ther. 3, 485–490.
Saulnier, S. O., Steinhoff, D., Dinauer, M. C, et al. (2000) Lentivirus-mediated gene transfer of gp91phox corrects chronic granulomatous disease (CGD) pheno-type in human X-CGD cells. J. Gene Med. 2, 317–325.
May, C., Rivella, S., Callegari, J., et al. (2000) Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin. Nature 406, 82–86.
Chinnasamy, N., Chinnasamy, D., Toso, J. F., et al. (2000) Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors. Hum. Gene Ther. 11, 1901–1909.
Stripecke, R., Cardoso, A. A., Pepper, K. A., et al. (2000) Lentiviral vectors for efficient delivery of CD80 and granulocyte-macrophage-colony-stimulating factor in human acute lymphoblastic leukemia and acute myeloid leukemia cells to induce antileukemic immune responses. Blood 96, 1317–1326.
Schroers, R., Sinha, I., Segall, H., et al. (2000) Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system. Mol. Ther. 1, 171–179.
Dyall, J., Latouche, J. B., Schnell, S., and Sadelain, M. (2001) Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes. Blood 97, 114–121.
Cremer, I., Vieillard, V., Sautes-Fridman, C., and De Maeyer, E. (2000) Inhibition of human immunodeficiency virus transmission to CD4+ T cells after gene transfer of constitutively expressed interferon beta to dendritic cells. Hum. Gene Ther. 11, 1695–1703.
Gruber, A., Kan-Mitchell, J., Kuhen, K. L., Mukai, T., and Wong-Staal, F. (2000) Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T-lymphocyte response in vitro. Blood 96, 1327–1333.
Evans, J. T., Cravens, P., Lipsky, P. E., and Garcia, J. V. (2000) Differentiation and expansion of lentivirus vector-marked dendritic cells derived from human CD34(+) cells. Hum. Gene Ther. 11, 2483–2492.
Neil, S., Martin, F., Ikeda, Y., and Collins, M. (2001) Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes. J. Virol. 75, 5448–5456.
Miyoshi, H., Takahashi, M., Gage, F. H., and Verma, I. M. (1997) Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc. Natl. Acad. Sci. USA 94, 10319–10323.
Takahashi, M., Miyoshi, H., Verma, I. M., and Gage, F. H. (1999) Rescue from photoreceptor degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene transfer. J. Virol. 73, 7812–7816.
Wang, X., Appukuttan, B., Ott, S., et al. (2000) Efficient and sustained transgene expression in human corneal cells mediated by a lentiviral vector. Gene Ther. 7, 196–200.
Galileo, D. S., Hunter, K., and Smith, S. B. (1999) Stable and efficient gene transfer into the mutant retinal pigment epithelial cells of the Mitf(vit) mouse using a lentiviral vector. Curr. Eye Res. 18, 135–142.
Gallichan, W.S, Kafri, T., Krahl, T., Verma, I. M., and Sarvetnick, N. (1998) Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis. Hum. Gene Ther. 9, 2717–2726.
Leibowitz, G., Beattie, G. M., Kafri, T., et al. (1999) Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes 48, 745–753.
Giannoukakis, N., Mi, Z., Gambotto, A., et al. (1999) Infection of intact human islets by a lentiviral vector. Gene Ther. 6, 1545–1551.
Johnston, J. C., Gasmi, M., Lim, L. E., et al. (1999) Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J. Virol. 73, 4991–5000.
Hamaguchi, I., Woods, N. B., Panagopoulos, I., et al. (2000) Lentivirus vector gene expression during ES cell-derived hematopoietic development in vitro. J. Virol. 74, 10778–10784.
Tarantal, A. F., O’Rourke, J. P., Case, S. S., et al. (2001) Rhesus monkey model for fetal gene transfer: studies with retroviral-based vector systems. Mol. Ther. 3, 128–138.
Wolfgang, M. J., Eisele, S. G., Browne, M. A., et al. (2001) Rhesus monkey placental transgene expression after lentiviral gene transfer into preimplantation embryos. Proc. Natl. Acad. Sci. USA 98, 10728–10732.
Park, F., Ohashi, K., Chiu, W., Naldini, L., and Kay, M. A. (2000) Efficient lentiviral transduction of liver requires cell cycling in vivo. Nat. Genet. 24, 49–52.
Korin, Y. D. and Zack, J. A. (1998) Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells. J. Virol. 72, 3161–3168.
Sutton, R. E., Reitsma, M. J., Uchida, N., and Brown, P. O. (1999) Transduction of human progenitor hematopoietic stem cells by human immunodeficiency virus type 1-based vectors is cell cycle dependent. J. Virol. 73, 3649–3660.
Schnell, T., Foley, P., Wirth, M., Munch, J., and Uberla, K. (2000) Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus. Hum. Gene Ther. 11, 439–447.
Negre, D., Mangeot, P. E., Duisit, G., et al. (2000) Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells. Gene Ther. 7, 1613–1623.
Nakajima, T., Nakamaru, K., Ido, E., Terao, K., Hayami, M., and Hasegawa, M. (2000) Development of novel simian immunodeficiency virus vectors carrying a dual gene expression system. Hum. Gene Ther. 11, 1863–1874.
Curran, M. A., Kaiser, S. M., Achacoso, P. L., and Nolan, G. P. (2000) Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors. Mol. Ther. 1, 31–38.
Wang, G., Slepushkin, V., Zabner, J., et al. (1999) Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect. J. Clin. Invest. 104, R55–R62.
Olsen, J. C. (1998) Gene transfer vectors derived from equine infectious anemia virus. Gene Ther. 5, 1481–1487.
Mitrophanous, K., Yoon, S., Rohll, J., et al. (1999) Stable gene transfer to the nervous system using a non-primate lentiviral vector. Gene Ther. 6, 1808–1818.
Berkowitz, R., Ilves, H., Lin, W. Y., et al. (2001) Construction and molecular analysis of gene transfer systems derived from bovine immunodeficiency virus. J. Virol. 75, 3371–3382.
Browning, M. T., Schmidt, R. D., Lew, K. A., and Rizvi, T. A. (2001) Primate and feline lentivirus vector rna packaging and propagation by heterologous lentivirus virions. J. Virol. 75, 5129–5140.
Rizvi, T. A. and Panganiban, A. T. (1993) Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency virus type 1 particles. J. Virol. 67, 2681–2688.
Hofmann, W., Schubert, D., LaBonte, J., et al. (1999) Species-specific, postentry barriers to primate immunodeficiency virus infection. J. Virol. 73, 10020–10028.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Kafri, T. (2004). Gene Delivery by Lentivirus Vectors. In: Heiser, W.C. (eds) Gene Delivery to Mammalian Cells. Methods in Molecular Biology™, vol 246. Humana Press. https://doi.org/10.1385/1-59259-650-9:367
Download citation
DOI: https://doi.org/10.1385/1-59259-650-9:367
Publisher Name: Humana Press
Print ISBN: 978-1-58829-095-3
Online ISBN: 978-1-59259-650-8
eBook Packages: Springer Protocols